Summary
Driven by rapid clinical translation, industrial-scale allogeneic production, and sustained publicprivate investment, the global stem cell manufacturing market is entering a decisive growth phase. Accelerating demand for clinical-grade stem cells, GMP-compli
Source: GlobeNewswire
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
